{"schema_version":"secwatch.filing_event.v1","accession":"0000929638-25-004243","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.933598+00:00","generated_at":"2026-05-16T20:09:13.940576+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CytoSorbents Reports Q3 2025 Revenue of $9.5M, Up 10% YoY, and Provides Business Update","bullets":["Revenue was $9.5 million for Q3 2025, a 10% increase from $8.6 million in Q3 2024, driven by record distributor sales.","Amended credit agreement with Avenue Capital Group added $2.5 million in term loans and extended interest-only period to December 31, 2026.","Workforce reduction of approximately 10% implemented to accelerate path to cash-flow breakeven by Q1 2026, with up to $900,000 in restructuring charges.","Pre-submission meeting request for DrugSorb-ATR De Novo application submitted to FDA; formal submission expected Q1 2026 with regulatory decision anticipated mid-2026.","Gross margin improved to 70% from 61% a year ago; operating loss narrowed to $2.9 million from $4.8 million."],"urls":{"canonical":"https://secwatch.observer/filing/0000929638-25-004243","json":"https://secwatch.observer/filing/0000929638-25-004243.json","markdown":"https://secwatch.observer/filing/0000929638-25-004243.md","text":"https://secwatch.observer/filing/0000929638-25-004243.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000092963825004243/0000929638-25-004243-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000092963825004243/a8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T20:09:13.940576+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}